Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Profilins | 5 | 2013 | 66 | 1.230 |
Why?
|
Endocrinology | 2 | 2020 | 443 | 0.940 |
Why?
|
Fellowships and Scholarships | 2 | 2020 | 1066 | 0.810 |
Why?
|
Telemedicine | 2 | 2023 | 2853 | 0.550 |
Why?
|
Uric Acid | 1 | 2020 | 760 | 0.490 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5724 | 0.480 |
Why?
|
Career Choice | 1 | 2020 | 743 | 0.470 |
Why?
|
Adipose Tissue, White | 2 | 2013 | 345 | 0.460 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2008 | 1121 | 0.420 |
Why?
|
Haploinsufficiency | 1 | 2013 | 329 | 0.400 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2023 | 436 | 0.360 |
Why?
|
Subcutaneous Fat | 1 | 2013 | 391 | 0.360 |
Why?
|
Glucose Intolerance | 1 | 2013 | 577 | 0.340 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.330 |
Why?
|
Ketocholesterols | 1 | 2008 | 3 | 0.320 |
Why?
|
STAT3 Transcription Factor | 2 | 2013 | 874 | 0.310 |
Why?
|
Receptors, Steroid | 1 | 2008 | 155 | 0.300 |
Why?
|
Insulin Resistance | 3 | 2014 | 3861 | 0.250 |
Why?
|
Receptors, LDL | 1 | 2007 | 475 | 0.250 |
Why?
|
Patient-Centered Care | 1 | 2015 | 1436 | 0.250 |
Why?
|
Pericytes | 3 | 2002 | 291 | 0.250 |
Why?
|
Lipoproteins, LDL | 2 | 2007 | 628 | 0.250 |
Why?
|
Uridine Triphosphate | 1 | 2023 | 26 | 0.240 |
Why?
|
Vasculitis | 1 | 2007 | 521 | 0.220 |
Why?
|
Inflammation | 2 | 2013 | 10578 | 0.220 |
Why?
|
Contractile Proteins | 1 | 2004 | 246 | 0.220 |
Why?
|
Physicians | 1 | 2020 | 4554 | 0.200 |
Why?
|
Endothelium, Vascular | 5 | 2007 | 4455 | 0.200 |
Why?
|
Atherosclerosis | 4 | 2015 | 3428 | 0.190 |
Why?
|
Hyperglycemia | 2 | 2017 | 1368 | 0.190 |
Why?
|
Xanthine Dehydrogenase | 1 | 2020 | 16 | 0.190 |
Why?
|
Blood Glucose | 3 | 2023 | 6249 | 0.180 |
Why?
|
Microfilament Proteins | 1 | 2004 | 1152 | 0.160 |
Why?
|
Ecosystem | 1 | 2022 | 471 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2002 | 1434 | 0.160 |
Why?
|
Microcirculation | 1 | 2002 | 1285 | 0.150 |
Why?
|
Endothelial Cells | 2 | 2008 | 3455 | 0.150 |
Why?
|
Purines | 1 | 2020 | 593 | 0.140 |
Why?
|
Retina | 3 | 2002 | 2611 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 11695 | 0.140 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2017 | 118 | 0.140 |
Why?
|
Antiemetics | 1 | 2017 | 176 | 0.130 |
Why?
|
NF-kappa B | 1 | 2002 | 2500 | 0.110 |
Why?
|
Macrophages | 3 | 2013 | 5655 | 0.110 |
Why?
|
Apoptosis | 4 | 2002 | 9715 | 0.100 |
Why?
|
Pilot Projects | 1 | 2023 | 8297 | 0.090 |
Why?
|
Antigens, Differentiation | 1 | 2013 | 926 | 0.090 |
Why?
|
Receptor, Insulin | 1 | 2014 | 846 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2283 | 0.090 |
Why?
|
Aorta | 3 | 2008 | 2057 | 0.090 |
Why?
|
Dexamethasone | 1 | 2017 | 1949 | 0.090 |
Why?
|
Diabetes Complications | 2 | 2015 | 1359 | 0.090 |
Why?
|
Perioperative Care | 1 | 2017 | 997 | 0.080 |
Why?
|
Retinal Vessels | 4 | 2002 | 769 | 0.080 |
Why?
|
Life Expectancy | 1 | 2015 | 1183 | 0.080 |
Why?
|
Peptide Library | 3 | 2004 | 350 | 0.080 |
Why?
|
Humans | 18 | 2023 | 742088 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 886 | 0.080 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1461 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2007 | 534 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2017 | 1457 | 0.070 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5304 | 0.060 |
Why?
|
Rats | 6 | 2010 | 24265 | 0.060 |
Why?
|
Janus Kinase 2 | 1 | 2008 | 527 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 707 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2007 | 689 | 0.060 |
Why?
|
Capillaries | 3 | 2002 | 774 | 0.060 |
Why?
|
Annexin A2 | 1 | 2004 | 44 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2039 | 0.060 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1504 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 2 | 2002 | 295 | 0.060 |
Why?
|
Medication Adherence | 1 | 2015 | 2055 | 0.060 |
Why?
|
Animals | 11 | 2014 | 168561 | 0.060 |
Why?
|
Cyclophilins | 1 | 2002 | 46 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 21821 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1788 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2008 | 8300 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8328 | 0.050 |
Why?
|
Homeostasis | 1 | 2013 | 3335 | 0.050 |
Why?
|
Thrombophilia | 1 | 2004 | 305 | 0.050 |
Why?
|
Diabetic Retinopathy | 2 | 2000 | 1205 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3869 | 0.050 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2004 | 434 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2007 | 1080 | 0.050 |
Why?
|
Weight Loss | 1 | 2012 | 2604 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10372 | 0.050 |
Why?
|
Heterozygote | 1 | 2007 | 2790 | 0.050 |
Why?
|
Obesity | 2 | 2013 | 12705 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 3 | 2002 | 4553 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3239 | 0.050 |
Why?
|
Guanidines | 1 | 2000 | 191 | 0.040 |
Why?
|
Mice | 5 | 2014 | 81045 | 0.040 |
Why?
|
Galactosemias | 1 | 2000 | 125 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 853 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
Alkaline Phosphatase | 1 | 2002 | 865 | 0.040 |
Why?
|
Signal Transduction | 4 | 2010 | 23387 | 0.040 |
Why?
|
Up-Regulation | 1 | 2008 | 4211 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.040 |
Why?
|
Limb Deformities, Congenital | 1 | 1999 | 136 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 4751 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12695 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9144 | 0.040 |
Why?
|
Young Adult | 1 | 2023 | 56350 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 1999 | 471 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5867 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2002 | 3770 | 0.030 |
Why?
|
Male | 8 | 2017 | 349538 | 0.030 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1884 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2002 | 3420 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2001 | 2014 | 0.030 |
Why?
|
DNA Primers | 2 | 2010 | 2892 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 677 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 817 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2007 | 14554 | 0.030 |
Why?
|
Cause of Death | 1 | 2002 | 3571 | 0.030 |
Why?
|
CHO Cells | 1 | 2014 | 1407 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12164 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1245 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2010 | 158 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4414 | 0.020 |
Why?
|
Cricetinae | 1 | 2014 | 2471 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5095 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 2 | 2000 | 643 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2001 | 13029 | 0.020 |
Why?
|
Risk Factors | 1 | 2015 | 72145 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.020 |
Why?
|
Models, Biological | 1 | 2004 | 9581 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3847 | 0.020 |
Why?
|
Base Sequence | 2 | 2010 | 12797 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2010 | 19223 | 0.020 |
Why?
|
Phosphorylation | 2 | 2010 | 8436 | 0.020 |
Why?
|
Fibrinolysin | 1 | 2004 | 131 | 0.010 |
Why?
|
Length of Stay | 1 | 2017 | 6294 | 0.010 |
Why?
|
Molecular Sequence Data | 3 | 2002 | 18112 | 0.010 |
Why?
|
Fibrinolysis | 1 | 2004 | 322 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1999 | 4566 | 0.010 |
Why?
|
Mutation | 2 | 2014 | 29717 | 0.010 |
Why?
|
DNA, Recombinant | 1 | 2002 | 475 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2004 | 1456 | 0.010 |
Why?
|
Receptors, Somatomedin | 1 | 2001 | 57 | 0.010 |
Why?
|
Female | 4 | 2017 | 379592 | 0.010 |
Why?
|
Aged | 4 | 2017 | 162944 | 0.010 |
Why?
|
Annexin A5 | 1 | 2000 | 103 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2004 | 627 | 0.010 |
Why?
|
Glucose | 2 | 2004 | 4391 | 0.010 |
Why?
|
Galactose | 1 | 2000 | 306 | 0.010 |
Why?
|
Bacteriophages | 1 | 2002 | 354 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2002 | 559 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1727 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2002 | 13814 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2000 | 411 | 0.010 |
Why?
|
Growth Hormone | 1 | 2001 | 703 | 0.010 |
Why?
|
Protein Transport | 1 | 2004 | 1988 | 0.010 |
Why?
|
Cattle | 1 | 2004 | 3923 | 0.010 |
Why?
|
Middle Aged | 3 | 2017 | 213127 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2088 | 0.010 |
Why?
|
Cadaver | 1 | 2001 | 1333 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4322 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6313 | 0.010 |
Why?
|
Cell Membrane | 1 | 2004 | 3744 | 0.010 |
Why?
|
Swine | 1 | 2004 | 5934 | 0.010 |
Why?
|
Syndrome | 1 | 1999 | 3248 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|
Blotting, Western | 1 | 2000 | 5180 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2001 | 2502 | 0.010 |
Why?
|
Cell Survival | 1 | 2000 | 5872 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2002 | 2229 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 77098 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 4801 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11363 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9639 | 0.000 |
Why?
|
Aging | 1 | 2001 | 8626 | 0.000 |
Why?
|
Time Factors | 1 | 2001 | 40054 | 0.000 |
Why?
|
Adult | 2 | 2004 | 213712 | 0.000 |
Why?
|
Infant | 1 | 1999 | 35070 | 0.000 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_